Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Scozzafava, A; Mastrolorenzo, A; Supuran, CT
   Arylsulfonyl-N,N-dialkyl-dithiocarbamates as tumor cell growth inhibitors:Novel agents targeting beta-tubulin?
   JOURNAL OF ENZYME INHIBITION
   
   A. Scozzafava et al., "Arylsulfonyl-N,N-dialkyl-dithiocarbamates as tumor cell growth inhibitors:Novel agents targeting beta-tubulin?", J ENZ INHIB, 16(1), 2001, pp. 55-63
2. Wipf, P; Methot, JL
   Synthetic studies toward diazonamide A. A novel approach for polyoxazole synthesis
   ORGANIC LETTERS
   
   P. Wipf e J.L. Methot, "Synthetic studies toward diazonamide A. A novel approach for polyoxazole synthesis", ORG LETT, 3(9), 2001, pp. 1261-1264
3. Vedejs, E; Zajac, MA
   Synthesis of the diazonamide A macrocyclic core via a Dieckmann-type cyclization
   ORGANIC LETTERS
   
   E. Vedejs e M.A. Zajac, "Synthesis of the diazonamide A macrocyclic core via a Dieckmann-type cyclization", ORG LETT, 3(16), 2001, pp. 2451-2454
4. Cossy, J; Pradaux, F; BouzBouz, S
   Synthesis of the C1-C12 fragment of fostriecin
   ORGANIC LETTERS
   
   J. Cossy et al., "Synthesis of the C1-C12 fragment of fostriecin", ORG LETT, 3(14), 2001, pp. 2233-2235
5. Li, J; Chen, X; Burgett, AWG; Harran, PG
   Synthetic seco forms of (-)-diazonamide A
   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
   
   J. Li et al., "Synthetic seco forms of (-)-diazonamide A", ANGEW CHEM, 40(14), 2001, pp. 2682-2685
6. Rosenhagen, MC; Young, JC; Wochnik, GM; Herr, AS; Schmidt, U; Hartl, FU; Holsboer, F; Rein, T
   Synergistic inhibition of the glucocorticoid receptor by radicicol and benzoquinone ansamycins
   BIOLOGICAL CHEMISTRY
   
   M.C. Rosenhagen et al., "Synergistic inhibition of the glucocorticoid receptor by radicicol and benzoquinone ansamycins", BIOL CHEM, 382(3), 2001, pp. 499-504
7. Sittler, A; Lurz, R; Lueder, G; Priller, J; Hayer-Hartl, MK; Hartl, FU; Lehrach, H; Wanker, EE
   Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease
   HUMAN MOLECULAR GENETICS
   
   A. Sittler et al., "Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease", HUM MOL GEN, 10(12), 2001, pp. 1307-1315
8. Guo, ML; Guo, ZJ; Sadler, PJ
   Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride
   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
   
   M.L. Guo et al., "Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride", J BIOL I CH, 6(7), 2001, pp. 698-707
9. Abe, S; Yamasaki, T; Nakano, K; Yoshikawa, I; Tabaru, A; Otsuki, M
   Multiple hepatic infarction after transcatheter arterial infusion with SMANCS
   JOURNAL OF GASTROENTEROLOGY
   
   S. Abe et al., "Multiple hepatic infarction after transcatheter arterial infusion with SMANCS", J GASTRO, 36(6), 2001, pp. 415-421
10. Lee, KW; Briggs, JM
    Comparative molecular field analysis (CoMFA) study of epothilones-tubulin depolymerization inhibitors: Pharmacophore development using 3D QSAR methods
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    
    K.W. Lee e J.M. Briggs, "Comparative molecular field analysis (CoMFA) study of epothilones-tubulin depolymerization inhibitors: Pharmacophore development using 3D QSAR methods", J COMPUT A, 15(1), 2001, pp. 41-55
11. Bai, FJ; Jones, DC; Lau, SS; Monks, TJ
    Serotonergic neurotoxicity of 3,4-(+/-) -methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase
    CHEMICAL RESEARCH IN TOXICOLOGY
    
    F.J. Bai et al., "Serotonergic neurotoxicity of 3,4-(+/-) -methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase", CHEM RES T, 14(7), 2001, pp. 863-870
12. Saleem, A; Harte, RJ; Matthews, JC; Osman, S; Brady, F; Luthra, SK; Brown, GD; Bleehen, N; Conners, T; Jones, T; Price, PM; Aboagye, EO
    Pharmacokinetic evaluation of N-[2(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography
    JOURNAL OF CLINICAL ONCOLOGY
    
    A. Saleem et al., "Pharmacokinetic evaluation of N-[2(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography", J CL ONCOL, 19(5), 2001, pp. 1421-1429
13. Cheung, AP; Struble, E; Nguyen, N; Liu, P
    Stability-indicating HPLC assay and solution stability of a new diaziridinyl benzoquinone
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    
    A.P. Cheung et al., "Stability-indicating HPLC assay and solution stability of a new diaziridinyl benzoquinone", J PHARM B, 24(5-6), 2001, pp. 957-966
14. Yama, N; Tsuchida, Y; Nuka, S; Kitagawa, S; Saito, J; Hyodoh, H; Hyodoh, K; Koito, K; Tamakawa, M; Akiba, H; Hareyama, M; Asai, Y
    Usefulness of magnetic resonance imaging for surgical management of extravasation of an antitumor agent: a case report
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    
    N. Yama et al., "Usefulness of magnetic resonance imaging for surgical management of extravasation of an antitumor agent: a case report", JPN J CLIN, 31(3), 2001, pp. 122-124
15. Nuijen, B; Bouma, M; Talsma, H; Manada, C; Jimeno, JM; Lopez-Lazaro, L; Bult, A; Beijnen, JH
    Development of a lyophilized parenteral pharmaceutical formulation of the investigational polypeptide marine anticancer agent kahalalide F
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    
    B. Nuijen et al., "Development of a lyophilized parenteral pharmaceutical formulation of the investigational polypeptide marine anticancer agent kahalalide F", DRUG DEV IN, 27(8), 2001, pp. 767-780
16. Egorin, MJ; Zuhowski, EG; Rosen, DM; Sentz, DL; Covey, JM; Eiseman, JL
    Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    M.J. Egorin et al., "Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1", CANC CHEMOT, 47(4), 2001, pp. 291-302
17. Kasuya, Y; Lu, ZR; Kopeckova, P; Minko, T; Tabibi, SE; Kopecek, J
    Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates
    JOURNAL OF CONTROLLED RELEASE
    
    Y. Kasuya et al., "Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates", J CONTR REL, 74(1-3), 2001, pp. 203-211
18. Nuijen, B; Bouma, M; Manada, C; Jimeno, JM; Lazaro, LL; Bult, A; Beijnen, JH
    Compatibility and stability of the investigational polypeptide marine anticancer agent kahalalide F in infusion devices
    INVESTIGATIONAL NEW DRUGS
    
    B. Nuijen et al., "Compatibility and stability of the investigational polypeptide marine anticancer agent kahalalide F in infusion devices", INV NEW DR, 19(4), 2001, pp. 273-281
19. Simamura, E; Hirai, KI; Shimada, H; Koyama, J
    Apoptosis and epithelial phagocytosis in mitomycin C-treated human pulmonary adenocarcinoma A549 cells
    TISSUE & CELL
    
    E. Simamura et al., "Apoptosis and epithelial phagocytosis in mitomycin C-treated human pulmonary adenocarcinoma A549 cells", TISSUE CELL, 33(2), 2001, pp. 161-168
20. Magnus, P; Lescop, C
    Photo-Fries rearrangement for the synthesis of the diazonamide macrocycle
    TETRAHEDRON LETTERS
    
    P. Magnus e C. Lescop, "Photo-Fries rearrangement for the synthesis of the diazonamide macrocycle", TETRAHEDR L, 42(41), 2001, pp. 7193-7196
21. Radspieler, A; Liebscher, J
    Synthesis of chlorooxazoles related to natural products
    SYNTHESIS-STUTTGART
    
    A. Radspieler e J. Liebscher, "Synthesis of chlorooxazoles related to natural products", SYNTHESIS-S, (5), 2001, pp. 745-750
22. Ahmed, A; Ohler, E; Mulzer, J
    Synthesis of (S)-4-methyl-3,6-dihydro-2H-pyran-2-carbaldehyde by two-directional ring closing metathesis: Application to the C27-C15-fragment of laulimalide
    SYNTHESIS-STUTTGART
    
    A. Ahmed et al., "Synthesis of (S)-4-methyl-3,6-dihydro-2H-pyran-2-carbaldehyde by two-directional ring closing metathesis: Application to the C27-C15-fragment of laulimalide", SYNTHESIS-S, (13), 2001, pp. 2007-2010
23. Vaughan, K
    Recent progress in the synthesis of bis-triazenes
    ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL
    
    K. Vaughan, "Recent progress in the synthesis of bis-triazenes", ORG PREP PR, 33(1), 2001, pp. 59
24. George, JW; Stohr, BA; Tomso, DJ; Kreuzer, KN
    The tight linkage between DNA replication and double-strand break repair in bacteriophage T4
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    J.W. George et al., "The tight linkage between DNA replication and double-strand break repair in bacteriophage T4", P NAS US, 98(15), 2001, pp. 8290-8297
25. Siegel, D; Anwar, A; Winski, SL; Kepa, JK; Zolman, KL; Ross, D
    Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H : Quinone oxidoreductase 1
    MOLECULAR PHARMACOLOGY
    
    D. Siegel et al., "Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H : Quinone oxidoreductase 1", MOLEC PHARM, 59(2), 2001, pp. 263-268
26. Bishop, CD; Bates, WR; Brandhorst, BP
    Regulation of metamorphosis in ascidians involves NO/cGMP signaling and HSP90
    JOURNAL OF EXPERIMENTAL ZOOLOGY
    
    C.D. Bishop et al., "Regulation of metamorphosis in ascidians involves NO/cGMP signaling and HSP90", J EXP ZOOL, 289(6), 2001, pp. 374-384
27. Stohr, BA; Kreuzer, KN
    Repair of topoisomerase-mediated DNA damage in bacteriophage T4
    GENETICS
    
    B.A. Stohr e K.N. Kreuzer, "Repair of topoisomerase-mediated DNA damage in bacteriophage T4", GENETICS, 158(1), 2001, pp. 19-28
28. Bocca, C; Gabriel, L; Miglietta, A
    Cytoskeleton-interacting activity of geiparvarin, diethylstilbestrol and conjugates
    CHEMICO-BIOLOGICAL INTERACTIONS
    
    C. Bocca et al., "Cytoskeleton-interacting activity of geiparvarin, diethylstilbestrol and conjugates", CHEM-BIO IN, 137(3), 2001, pp. 285-305
29. Leroy, D; Kajava, AV; Frei, C; Gasser, SM
    Analysis of etoposide binding to subdomains of human DNA topoisomerase II alpha in the absence of DNA
    BIOCHEMISTRY
    
    D. Leroy et al., "Analysis of etoposide binding to subdomains of human DNA topoisomerase II alpha in the absence of DNA", BIOCHEM, 40(6), 2001, pp. 1624-1634
30. Hoppen, S; Emde, U; Friedrich, T; Grubert, L; Koert, U
    Natural-product hybrids: Design, synthesis, and biological evaluation of quinone-annonaceous acetogenins
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    
    S. Hoppen et al., "Natural-product hybrids: Design, synthesis, and biological evaluation of quinone-annonaceous acetogenins", ANGEW CHEM, 39(12), 2000, pp. 2099
31. Long, BH; Balasubramanian, BN
    Non-camptothecin topoisomerase I active compounds as potential anticancer agents
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    B.H. Long e B.N. Balasubramanian, "Non-camptothecin topoisomerase I active compounds as potential anticancer agents", EXPERT OP T, 10(5), 2000, pp. 635-666
32. Ohya, Y; Shirakawa, S; Matsumoto, M; Ouchi, T
    Design of poly(ethylene glycol) immobilizing platinum complex through chelate-type coordination bond
    POLYMERS FOR ADVANCED TECHNOLOGIES
    
    Y. Ohya et al., "Design of poly(ethylene glycol) immobilizing platinum complex through chelate-type coordination bond", POLYM ADV T, 11(8-12), 2000, pp. 635-641
33. Owa, T; Okauchi, T; Yoshimatsu, K; Sugi, NH; Ozawa, Y; Nagasu, T; Koyanagi, N; Okabe, T; Kitoh, K; Yoshino, H
    A focused compound library of novel N-(7-indolyl)benzenesulfonamides for the discovery of potent cell cycle inhibitors
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    T. Owa et al., "A focused compound library of novel N-(7-indolyl)benzenesulfonamides for the discovery of potent cell cycle inhibitors", BIOORG MED, 10(11), 2000, pp. 1223-1226
34. Baek, H; Cho, Y; Lee, CO; Sohn, YS
    Synthesis and antitumor activity of cyclotriphosphazene-(diamine)platinum(II) conjugates
    ANTI-CANCER DRUGS
    
    H. Baek et al., "Synthesis and antitumor activity of cyclotriphosphazene-(diamine)platinum(II) conjugates", ANTI-CANC D, 11(9), 2000, pp. 715-725
35. Jiang, XF; Zhen, YS
    Cinnamamide, an antitumor agent with low cytotoxicity acting on matrix metalloproteinase
    ANTI-CANCER DRUGS
    
    X.F. Jiang e Y.S. Zhen, "Cinnamamide, an antitumor agent with low cytotoxicity acting on matrix metalloproteinase", ANTI-CANC D, 11(1), 2000, pp. 49-54
36. Hoppen, S; Baurle, S; Koert, U
    A convergent total synthesis of (-)-mucocin: An acetogenin from Annonaceae
    CHEMISTRY-A EUROPEAN JOURNAL
    
    S. Hoppen et al., "A convergent total synthesis of (-)-mucocin: An acetogenin from Annonaceae", CHEM-EUR J, 6(13), 2000, pp. 2382-2396
37. Ikeda, K; Saitoh, S; Kobayashi, M; Suzuki, Y; Suzuki, F; Tsubota, A; Arase, Y; Chayama, K; Murashima, N; Kumada, H
    Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma
    JOURNAL OF GASTROENTEROLOGY
    
    K. Ikeda et al., "Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma", J GASTRO, 35(5), 2000, pp. 353-360
38. Stevens, GJ; Burkey, JL; McQueen, CA
    Toxicity of the heterocyclic amine batracylin: investigation of rodent N-acetyltransferase activity and potential contribution of cytochrome P450 3A
    CELL BIOLOGY AND TOXICOLOGY
    
    G.J. Stevens et al., "Toxicity of the heterocyclic amine batracylin: investigation of rodent N-acetyltransferase activity and potential contribution of cytochrome P450 3A", CELL BIOL T, 16(1), 2000, pp. 31-39
39. Bajic, V; Stanimirovic, Z; Markovic, B
    Examination of 8-Cl-cAMP genotoxicity by two in vivo test in BALB/c strainmice
    ACTA VETERINARIA-BEOGRAD
    
    V. Bajic et al., "Examination of 8-Cl-cAMP genotoxicity by two in vivo test in BALB/c strainmice", ACT VET BEO, 50(2-3), 2000, pp. 177-190
40. Iimura, S; Ohsuki, S; Uoto, K; Nakayama, K; Terasawa, H; Soga, T
    A convenient method for the synthesis of C-10 alkylated docetaxel analogs using tris-(trimethylsilyl)silane as a radical mediator
    HETEROCYCLES
    
    S. Iimura et al., "A convenient method for the synthesis of C-10 alkylated docetaxel analogs using tris-(trimethylsilyl)silane as a radical mediator", HETEROCYCLE, 53(7), 2000, pp. 1579-1582
41. Hrushesky, WJM
    The temporal organization of life: the impact of multi-frequency non-linear biologic time structure upon the host-cancer balance
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    
    W.J.M. Hrushesky, "The temporal organization of life: the impact of multi-frequency non-linear biologic time structure upon the host-cancer balance", JPN J CLIN, 30(12), 2000, pp. 529-533
42. Giribone, D; Fontana, E
    Synthesis of the taxane analogue PNU-105298 labelled with deuterium and with carbon-14
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    
    D. Giribone e E. Fontana, "Synthesis of the taxane analogue PNU-105298 labelled with deuterium and with carbon-14", J LABEL C R, 43(9), 2000, pp. 933-941
43. Pan, JH; Simamura, E; Koyama, J; Shimada, H; Hirai, KI
    Induced apoptosis and necrosis by 2-methylfuranonaphthoquinone in human cervical cancer HeLa cells
    CANCER DETECTION AND PREVENTION
    
    J.H. Pan et al., "Induced apoptosis and necrosis by 2-methylfuranonaphthoquinone in human cervical cancer HeLa cells", CANCER DET, 24(3), 2000, pp. 266-274
44. Lewis, JR
    Amaryllidaceae, muscarine, imidazole, oxazole, thiazole and peptide alkaloids, and other miscellaneous alkaloids
    NATURAL PRODUCT REPORTS
    
    J.R. Lewis, "Amaryllidaceae, muscarine, imidazole, oxazole, thiazole and peptide alkaloids, and other miscellaneous alkaloids", NAT PROD R, 17(1), 2000, pp. 57-84
45. Pieper, M; Rupprecht, HD; Bruch, KM; de Heer, E; Schocklmann, HO
    Requirement of heat shock protein 90 in mesangial cell mitogenesis
    KIDNEY INTERNATIONAL
    
    M. Pieper et al., "Requirement of heat shock protein 90 in mesangial cell mitogenesis", KIDNEY INT, 58(6), 2000, pp. 2377-2389
46. Sharp, SY; Kelland, LR; Valenti, MR; Brunton, LA; Hobbs, S; Workman, P
    Establishment of an isogenic human colon tumor model for NQO1 gene expression: Application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo
    MOLECULAR PHARMACOLOGY
    
    S.Y. Sharp et al., "Establishment of an isogenic human colon tumor model for NQO1 gene expression: Application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo", MOLEC PHARM, 58(5), 2000, pp. 1146-1155
47. Wang, YQ; Yuan, HL; Ye, WQ; Wright, SC; Wang, H; Larrick, JW
    Synthesis and preliminary biological evaluations of CC-1065 analogues: Effects of different linkers and terminal amides on biological activity
    JOURNAL OF MEDICINAL CHEMISTRY
    
    Y.Q. Wang et al., "Synthesis and preliminary biological evaluations of CC-1065 analogues: Effects of different linkers and terminal amides on biological activity", J MED CHEM, 43(8), 2000, pp. 1541-1549
48. Yorgin, PD; Hartson, SD; Fellah, AM; Scroggins, BT; Huang, WJ; Katsanis, E; Couchman, JM; Matts, RL; Whitesell, L
    Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases
    JOURNAL OF IMMUNOLOGY
    
    P.D. Yorgin et al., "Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases", J IMMUNOL, 164(6), 2000, pp. 2915-2923
49. Fuller, W; Cuthbert, AW
    Post-translational disruption of the Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes Delta F508 CFTR in the rabbit reticulocyte lysate
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    W. Fuller e A.W. Cuthbert, "Post-translational disruption of the Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes Delta F508 CFTR in the rabbit reticulocyte lysate", J BIOL CHEM, 275(48), 2000, pp. 37462-37468
50. Melendez, E; Marrero, M; Rivera, C; Hernandez, E; Segal, A
    Spectroscopic characterization of titanocene complexes with thionucleobases
    INORGANICA CHIMICA ACTA
    
    E. Melendez et al., "Spectroscopic characterization of titanocene complexes with thionucleobases", INORG CHIM, 298(2), 2000, pp. 178-186
51. Teran, C; Santana, L; Teijeira, M; Uriarte, E; De Clercq, E
    Design, synthesis, conformational analysis and biological activities of purine-based 1,2-di-substituted carbocyclic nucleosides
    CHEMICAL & PHARMACEUTICAL BULLETIN
    
    C. Teran et al., "Design, synthesis, conformational analysis and biological activities of purine-based 1,2-di-substituted carbocyclic nucleosides", CHEM PHARM, 48(2), 2000, pp. 293-295
52. Ishikawa, S; Saitoh, N; Mochizuki, M
    Synthesis and properties of novel bifunctional nitrosamines with omega-chloroalkyl groups
    CHEMICAL & PHARMACEUTICAL BULLETIN
    
    S. Ishikawa et al., "Synthesis and properties of novel bifunctional nitrosamines with omega-chloroalkyl groups", CHEM PHARM, 48(10), 2000, pp. 1500-1503
53. Roberge, M; Cinel, B; Anderson, HJ; Lim, L; Jiang, XX; Xu, L; Bigg, CM; Kelly, MT; Andersen, RJ
    Cell-based screen for antimitotic agents and identification of analogues of rhizoxin, eleutherobin, and paclitaxel in natural extracts
    CANCER RESEARCH
    
    M. Roberge et al., "Cell-based screen for antimitotic agents and identification of analogues of rhizoxin, eleutherobin, and paclitaxel in natural extracts", CANCER RES, 60(18), 2000, pp. 5052-5058
54. Padget, K; Stewart, A; Charlton, P; Tilby, MJ; Austin, CA
    An investigation into the formation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 6-[2-(dimethylamino)ethylamino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103) stabilised DNA topoisomerase I and II cleavable complexes in human leukaemia cells
    BIOCHEMICAL PHARMACOLOGY
    
    K. Padget et al., "An investigation into the formation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 6-[2-(dimethylamino)ethylamino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103) stabilised DNA topoisomerase I and II cleavable complexes in human leukaemia cells", BIOCH PHARM, 60(6), 2000, pp. 817-821
55. Dassonneville, L; Wattez, N; Baldeyrou, B; Mahieu, C; Lansiaux, A; Banaigs, B; Bonnard, I; Bailly, C
    Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells
    BIOCHEMICAL PHARMACOLOGY
    
    L. Dassonneville et al., "Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells", BIOCH PHARM, 60(4), 2000, pp. 527-537
56. Loadman, PM; Phillips, RM; Lim, LE; Bibby, MC
    Pharmacological properties of a new aziridinylbenzoquinone, RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone), in mice
    BIOCHEMICAL PHARMACOLOGY
    
    P.M. Loadman et al., "Pharmacological properties of a new aziridinylbenzoquinone, RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone), in mice", BIOCH PHARM, 59(7), 2000, pp. 831-837
57. Boger, DL; Cai, H
    Bleomycin: Synthetic and mechanistic studies
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    
    D.L. Boger e H. Cai, "Bleomycin: Synthetic and mechanistic studies", ANGEW CHEM, 38(4), 1999, pp. 449-476
58. Low, KB; Ittensohn, M; Le, T; Platt, J; Sodi, S; Amoss, M; Ash, O; Carmichael, E; Chakraborty, A; Fischer, J; Lin, SL; Luo, X; Miller, SI; Zheng, LM; King, I; Pawelek, JM; Bermudes, D
    Lipid A mutant Salmonella with suppressed virulence and TNF alpha induction retain tumor-targeting in vivo
    NATURE BIOTECHNOLOGY
    
    K.B. Low et al., "Lipid A mutant Salmonella with suppressed virulence and TNF alpha induction retain tumor-targeting in vivo", NAT BIOTECH, 17(1), 1999, pp. 37-41
59. Loadman, PM; Bibby, MC; Double, JA; Al-Shakhaa, WM; Duncan, R
    Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor modelswith differing responses to PK1
    CLINICAL CANCER RESEARCH
    
    P.M. Loadman et al., "Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor modelswith differing responses to PK1", CLIN CANC R, 5(11), 1999, pp. 3682-3688
60. Morre, DJ; Grieco, PA
    Glaucarubolone and simalikalactone D, respectively, preferentially inhibitauxin-induced and constitutive components of plant cell enlargement and the plasma membrane NADH oxidase
    INTERNATIONAL JOURNAL OF PLANT SCIENCES
    
    D.J. Morre e P.A. Grieco, "Glaucarubolone and simalikalactone D, respectively, preferentially inhibitauxin-induced and constitutive components of plant cell enlargement and the plasma membrane NADH oxidase", INT J PL SC, 160(2), 1999, pp. 291-297
61. Kellogg, GE; Scarsdale, JN; Cashman, DJ
    Ligand docking and scoring in DNA oligonucleotides. Binding of doxorubicinand modeled analogs to optimize sequence specificity
    MEDICINAL CHEMISTRY RESEARCH
    
    G.E. Kellogg et al., "Ligand docking and scoring in DNA oligonucleotides. Binding of doxorubicinand modeled analogs to optimize sequence specificity", MED CHEM RE, 9(7-8), 1999, pp. 592-603
62. Buchner, J
    Hsp90 & Co. - a holding for folding
    TRENDS IN BIOCHEMICAL SCIENCES
    
    J. Buchner, "Hsp90 & Co. - a holding for folding", TRENDS BIOC, 24(4), 1999, pp. 136-141
63. Kestell, P; Dunlop, IC; McCrystal, MR; Evans, BD; Paxton, JW; Gamage, RSKA; Baguley, BC
    Plasma pharmacokinetics of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in a phase I trial
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    P. Kestell et al., "Plasma pharmacokinetics of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in a phase I trial", CANC CHEMOT, 44(1), 1999, pp. 45-50
64. Schofield, PC; Robertson, IGC; Paxton, JW; McCrystal, MR; Evans, BD; Kestell, P; Baguley, BC
    Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trial
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    P.C. Schofield et al., "Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trial", CANC CHEMOT, 44(1), 1999, pp. 51-58
65. Tatsuta, N; Suzuki, H; Mochizuki, T; Koya, K; Kawakami, M; Shishido, T; Motoji, N; Kuroiwa, H; Shigematsu, A; Chen, LB
    Pharmacokinetic analysis and antitumor efficacy of MKT-077, a novel antitumor agent
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    N. Tatsuta et al., "Pharmacokinetic analysis and antitumor efficacy of MKT-077, a novel antitumor agent", CANC CHEMOT, 43(4), 1999, pp. 295-301
66. Koyama, S; Tanaka, S; Haniu, H; Yamaguchi, Y; Motoyoshiya, J
    Yoshixol(TR) inhibits B16 melanoma cell growth in vivo and induces apoptosis-like (quantum thermodynamic) cell death
    GENERAL PHARMACOLOGY
    
    S. Koyama et al., "Yoshixol(TR) inhibits B16 melanoma cell growth in vivo and induces apoptosis-like (quantum thermodynamic) cell death", GEN PHARM, 33(2), 1999, pp. 161-172
67. Tanaka, S; Koyama, S; Haniu, H; Yamaguchi, Y; Motoyoshiya, J
    In vitro and in vivo antiturnor activity of Yoshixol(TR) against murine L1210 leukemic cells
    GENERAL PHARMACOLOGY
    
    S. Tanaka et al., "In vitro and in vivo antiturnor activity of Yoshixol(TR) against murine L1210 leukemic cells", GEN PHARM, 33(2), 1999, pp. 179-186
68. Kim, DK; Lee, JR; Kim, A; Lee, S; Yoo, MA; Kim, KW; Kim, ND; Suh, H
    Inhibition of initiation of simian virus 40 DNA replication in vitro by the ursodeoxycholic acid and its derivatives
    CANCER LETTERS
    
    D.K. Kim et al., "Inhibition of initiation of simian virus 40 DNA replication in vitro by the ursodeoxycholic acid and its derivatives", CANCER LETT, 146(2), 1999, pp. 147-153
69. Morano, KA; Santoro, N; Koch, KA; Thiele, DJ
    A trans-activation domain in yeast heat shock transcription factor is essential for cell cycle progression during stress
    MOLECULAR AND CELLULAR BIOLOGY
    
    K.A. Morano et al., "A trans-activation domain in yeast heat shock transcription factor is essential for cell cycle progression during stress", MOL CELL B, 19(1), 1999, pp. 402-411
70. Choi, BG; Kwak, EY; Chung, BH; Cho, WJ; Cheon, SH
    Synthesis of sesquiterpene derivatives as potential antitumor agents; Elemane derivatives
    ARCHIVES OF PHARMACAL RESEARCH
    
    B.G. Choi et al., "Synthesis of sesquiterpene derivatives as potential antitumor agents; Elemane derivatives", ARCH PH RES, 22(6), 1999, pp. 575-578
71. Stevens, GJ; Payton, M; Sim, E; McQueen, CA
    N-acetylation of the heterocyclic amine batracylin by human liver
    DRUG METABOLISM AND DISPOSITION
    
    G.J. Stevens et al., "N-acetylation of the heterocyclic amine batracylin by human liver", DRUG META D, 27(9), 1999, pp. 966-971
72. Kinugawa, M; Arai, H; Ogasa, T; Kasai, M
    Development of large-scale synthetic process for antitumor agent EO9
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN
    
    M. Kinugawa et al., "Development of large-scale synthetic process for antitumor agent EO9", J SYN ORG J, 57(5), 1999, pp. 401-406
73. Byrd, CA; Bornmann, W; Erdjument-Bromage, H; Tempst, P; Pavletich, N; Rosen, N; Nathan, CF; Ding, A
    Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    C.A. Byrd et al., "Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide", P NAS US, 96(10), 1999, pp. 5645-5650
74. Guano, F; Pourquier, P; Tinelli, S; Binaschi, M; Bigioni, M; Animati, F; Manzini, S; Zunino, F; Kohlhagen, G; Pommier, Y; Capranico, G
    Topoisomerase poisoning activity of novel disaccharide anthracyclines
    MOLECULAR PHARMACOLOGY
    
    F. Guano et al., "Topoisomerase poisoning activity of novel disaccharide anthracyclines", MOLEC PHARM, 56(1), 1999, pp. 77-84
75. Okada, H; Kato, M; Koyanagi, T; Mizuno, K
    Synthesis and antitumor activities of water-soluble benzoylphenylureas
    CHEMICAL & PHARMACEUTICAL BULLETIN
    
    H. Okada et al., "Synthesis and antitumor activities of water-soluble benzoylphenylureas", CHEM PHARM, 47(3), 1999, pp. 430-433
76. Twelves, CJ; Gardner, C; Flavin, A; Sludden, J; Dennis, I; de Bono, J; Beale, P; Vasey, P; Hutchison, C; Macham, MA; Rodriguez, A; Judson, I; Bleehen, NM
    Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II
    BRITISH JOURNAL OF CANCER
    
    C.J. Twelves et al., "Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II", BR J CANC, 80(11), 1999, pp. 1786-1791
77. Ando, RA; Morrical, SW
    Relationship between hexamerization and ssDNA binding affinity in the uvsYrecombination protein of bacteriophage T4
    BIOCHEMISTRY
    
    R.A. Ando e S.W. Morrical, "Relationship between hexamerization and ssDNA binding affinity in the uvsYrecombination protein of bacteriophage T4", BIOCHEM, 38(50), 1999, pp. 16589-16598
78. Kelland, LR; Sharp, SY; Rogers, PM; Myers, TG; Workman, P
    DT-diaphorase expression and tumor cell sensitivity to 17-allylamino,17-demethoxygeldanamycin, an inhibitor of heat shock protein 90
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    L.R. Kelland et al., "DT-diaphorase expression and tumor cell sensitivity to 17-allylamino,17-demethoxygeldanamycin, an inhibitor of heat shock protein 90", J NAT CANC, 91(22), 1999, pp. 1940-1949
79. NOTEBORN MHM; ZHANG YH; VANDEREB AJ
    APOPTIN(R) SPECIFICALLY CAUSES APOPTOSIS IN TUMOR-CELLS AND AFTER UV-TREATMENT IN UNTRANSFORMED CELLS FROM CANCER-PRONE INDIVIDUALS - A REVIEW
    Mutation research. Fundamental and molecular mechanisms of mutagenesis
    
    M.H.M. Noteborn et al., "APOPTIN(R) SPECIFICALLY CAUSES APOPTOSIS IN TUMOR-CELLS AND AFTER UV-TREATMENT IN UNTRANSFORMED CELLS FROM CANCER-PRONE INDIVIDUALS - A REVIEW", Mutation research. Fundamental and molecular mechanisms of mutagenesis, 400(1-2), 1998, pp. 447-455
80. CHINNASAMY N; FAIRBAIRN LJ; LAHER J; WILLINGTON MA; RAFFERTY JA
    MODULATION OF O-6-ALKYLATING AGENT INDUCED CLASTOGENICITY BY ENHANCEDDNA-REPAIR CAPACITY OF BONE-MARROW CELLS
    Mutation research. Genetic toxicology and environmental mutagenesis
    
    N. Chinnasamy et al., "MODULATION OF O-6-ALKYLATING AGENT INDUCED CLASTOGENICITY BY ENHANCEDDNA-REPAIR CAPACITY OF BONE-MARROW CELLS", Mutation research. Genetic toxicology and environmental mutagenesis, 416(1-2), 1998, pp. 1-10
81. BELANGER KG; KREUZER KN
    BACTERIOPHAGE-T4 INITIATES BIDIRECTIONAL DNA-REPLICATION THROUGH A 2-STEP PROCESS
    MOLECULAR CELL
    
    K.G. Belanger e K.N. Kreuzer, "BACTERIOPHAGE-T4 INITIATES BIDIRECTIONAL DNA-REPLICATION THROUGH A 2-STEP PROCESS", MOLECULAR CELL, 2(5), 1998, pp. 693-701
82. ADJEI AA; CHARRON M; ROWINSKY EK; SVINGEN PA; MILLER J; REID JM; SEBOLTLEOPOLD J; AMES MM; KAUFMANN SH
    EFFECT OF PYRAZOLOACRIDINE (NSC-366140) ON DNA TOPOISOMERASE-I AND TOPOISOMERASE-II
    Clinical cancer research
    
    A.A. Adjei et al., "EFFECT OF PYRAZOLOACRIDINE (NSC-366140) ON DNA TOPOISOMERASE-I AND TOPOISOMERASE-II", Clinical cancer research, 4(3), 1998, pp. 683-691
83. ADJEI AA; CHARRON M; ROWINSKY EK; SVINGEN PA; MILLER J; REID JM; SEBOLTLEOPOLD J; AMES MM; KAUFMANN SH
    EFFECT OF PYRAZOLOACRIDINE (NSC-366140) ON DNA TOPOISOMERASE-I AND TOPOISOMERASE-II
    Clinical cancer research
    
    A.A. Adjei et al., "EFFECT OF PYRAZOLOACRIDINE (NSC-366140) ON DNA TOPOISOMERASE-I AND TOPOISOMERASE-II", Clinical cancer research, 4(3), 1998, pp. 683-691
84. OZAKI S; KONG XZ; WATANABE Y; HOSHIKO T; OGASAWARA T; UENO T; FURUKAWA U; IIGO M; HOSHI A
    5-FLUOROURACIL DERIVATIVES - XXIII - SYNTHESIS AND ANTITUMOR ACTIVITIES OF 1-CARBAMOYL-5-FLUOROURACILS HAVING AROMATIC RING
    Chinese journal of chemistry
    
    S. Ozaki et al., "5-FLUOROURACIL DERIVATIVES - XXIII - SYNTHESIS AND ANTITUMOR ACTIVITIES OF 1-CARBAMOYL-5-FLUOROURACILS HAVING AROMATIC RING", Chinese journal of chemistry, 16(2), 1998, pp. 171-177
85. LU W; ZHENG GR; CAI JC
    FIRST TOTAL SYNTHESIS OF PANAXYTRIOL, A POTENT ANTITUMOR AGENT ISOLATED FROM PANAX-GINSENG
    Synlett
    
    W. Lu et al., "FIRST TOTAL SYNTHESIS OF PANAXYTRIOL, A POTENT ANTITUMOR AGENT ISOLATED FROM PANAX-GINSENG", Synlett, (7), 1998, pp. 737-738
86. GAN YB; AU JLS; LU J; WIENTJES MG
    ANTIPROLIFERATIVE AND CYTOTOXIC EFFECTS OF GELDANAMYCIN, CYTOCHALASIN-E, SURAMIN AND THIACETAZONE IN HUMAN PROSTATE XENOGRAFT TUMOR HISTOCULTURES
    Pharmaceutical research
    
    Y.B. Gan et al., "ANTIPROLIFERATIVE AND CYTOTOXIC EFFECTS OF GELDANAMYCIN, CYTOCHALASIN-E, SURAMIN AND THIACETAZONE IN HUMAN PROSTATE XENOGRAFT TUMOR HISTOCULTURES", Pharmaceutical research, 15(11), 1998, pp. 1760-1766
87. SCHULTE TW; NECKERS LM
    THE BENZOQUINONE ANSAMYCIN 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN BINDS TO HSP90 AND SHARES IMPORTANT BIOLOGIC ACTIVITIES WITH GELDANAMYCIN
    Cancer chemotherapy and pharmacology
    
    T.W. Schulte e L.M. Neckers, "THE BENZOQUINONE ANSAMYCIN 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN BINDS TO HSP90 AND SHARES IMPORTANT BIOLOGIC ACTIVITIES WITH GELDANAMYCIN", Cancer chemotherapy and pharmacology, 42(4), 1998, pp. 273-279
88. BRUNTON VG; STEELE G; LEWIS AD; WORKMAN P
    GELDANAMYCIN-INDUCED CYTOTOXICITY IN HUMAN COLON-CANCER CELL-LINES - EVIDENCE AGAINST THE INVOLVEMENT OF C-SRC OR DT-DIAPHORASE
    Cancer chemotherapy and pharmacology
    
    V.G. Brunton et al., "GELDANAMYCIN-INDUCED CYTOTOXICITY IN HUMAN COLON-CANCER CELL-LINES - EVIDENCE AGAINST THE INVOLVEMENT OF C-SRC OR DT-DIAPHORASE", Cancer chemotherapy and pharmacology, 41(5), 1998, pp. 417-422
89. SAKO M; SUZUKI H; YAMAMOTO N; HIROTA K; MAKI Y
    CONVENIENT METHODS FOR REGIO-SELECTIVE AND OR CHEMO-SELECTIVE O-DEACYLATION OF TAXININE, A NATURALLY-OCCURRING TAXANE DITERPENOID/
    Journal of the Chemical Society. Perkin transactions. I
    
    M. Sako et al., "CONVENIENT METHODS FOR REGIO-SELECTIVE AND OR CHEMO-SELECTIVE O-DEACYLATION OF TAXININE, A NATURALLY-OCCURRING TAXANE DITERPENOID/", Journal of the Chemical Society. Perkin transactions. I, (3), 1998, pp. 417-421
90. IMBERT TF
    DISCOVERY OF PODOPHYLLOTOXINS
    Biochimie
    
    T.F. Imbert, "DISCOVERY OF PODOPHYLLOTOXINS", Biochimie, 80(3), 1998, pp. 207-222
91. CHOI BC; KIM OY; CHUNG BH; CHO WJ; CHEON SH; CHOI SU; LEE CO
    SYNTHESIS OF ANTINEOPLASTON A10 ANALOGS AS POTENTIAL ANTITUMOR AGENTS
    Archives of pharmacal research
    
    B.C. Choi et al., "SYNTHESIS OF ANTINEOPLASTON A10 ANALOGS AS POTENTIAL ANTITUMOR AGENTS", Archives of pharmacal research, 21(2), 1998, pp. 157-163
92. TSUNODA S; YAMAMOTO K; SAKAMOTO S; INOUE H; NAGASAWA H
    EFFECTS OF SASA HEALTH(R), EXTRACT OF BAMBOO GRASS LEAVES, ON SPONTANEOUS MAMMARY TUMORIGENESIS IN SHN MICE
    Anticancer research
    
    S. Tsunoda et al., "EFFECTS OF SASA HEALTH(R), EXTRACT OF BAMBOO GRASS LEAVES, ON SPONTANEOUS MAMMARY TUMORIGENESIS IN SHN MICE", Anticancer research, 18(1A), 1998, pp. 153-158
93. KREUZER KN
    BACTERIOPHAGE-T4, A MODEL SYSTEM FOR UNDERSTANDING THE MECHANISM OF TYPE-II TOPOISOMERASE INHIBITORS
    Biochimica et biophysica acta, N. Gene structure and expression
    
    K.N. Kreuzer, "BACTERIOPHAGE-T4, A MODEL SYSTEM FOR UNDERSTANDING THE MECHANISM OF TYPE-II TOPOISOMERASE INHIBITORS", Biochimica et biophysica acta, N. Gene structure and expression, 1400(1-3), 1998, pp. 339-347
94. CONNELLY JC; KIRKHAM LA; LEACH DRF
    THE SBCCD NUCLEASE OF ESCHERICHIA-COLI IS A STRUCTURAL MAINTENANCE OFCHROMOSOMES (SMC) FAMILY PROTEIN THAT CLEAVES HAIRPIN DNA
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    J.C. Connelly et al., "THE SBCCD NUCLEASE OF ESCHERICHIA-COLI IS A STRUCTURAL MAINTENANCE OFCHROMOSOMES (SMC) FAMILY PROTEIN THAT CLEAVES HAIRPIN DNA", Proceedings of the National Academy of Sciences of the United Statesof America, 95(14), 1998, pp. 7969-7974
95. KOHLHAGEN G; PAULL KD; CUSHMAN M; NAGAFUJI P; POMMIER Y
    PROTEIN-LINKED DNA STRAND BREAKS INDUCED BY NSC-314622, A NOVEL NONCAMPTOTHECIN TOPOISOMERASE-I POISON
    Molecular pharmacology
    
    G. Kohlhagen et al., "PROTEIN-LINKED DNA STRAND BREAKS INDUCED BY NSC-314622, A NOVEL NONCAMPTOTHECIN TOPOISOMERASE-I POISON", Molecular pharmacology, 54(1), 1998, pp. 50-58
96. Pike, SE; Yao, L; Jones, KD; Cherney, B; Appella, E; Sakaguchi, K; Nakhasi, H; Teruya-Feldstein, J; Wirth, P; Gupta, G; Tosato, G
    Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    S.E. Pike et al., "Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth", J EXP MED, 188(12), 1998, pp. 2349-2356
97. FORTUNE JM; OSHEROFF N
    MERBARONE INHIBITS THE CATALYTIC ACTIVITY OF HUMAN TOPOISOMERASE II-ALPHA BY BLOCKING DNA CLEAVAGE
    The Journal of biological chemistry
    
    J.M. Fortune e N. Osheroff, "MERBARONE INHIBITS THE CATALYTIC ACTIVITY OF HUMAN TOPOISOMERASE II-ALPHA BY BLOCKING DNA CLEAVAGE", The Journal of biological chemistry, 273(28), 1998, pp. 17643-17650
98. WANG FJ; RIPLEY LS
    THE SPECTRUM OF ACRIDINE RESISTANT MUTANTS OF BACTERIOPHAGE-T4 REVEALS CRYPTIC EFFECTS OF THE TSL141 DNA-POLYMERASE ALLELE ON SPONTANEOUS MUTAGENESIS
    Genetics
    
    F.J. Wang e L.S. Ripley, "THE SPECTRUM OF ACRIDINE RESISTANT MUTANTS OF BACTERIOPHAGE-T4 REVEALS CRYPTIC EFFECTS OF THE TSL141 DNA-POLYMERASE ALLELE ON SPONTANEOUS MUTAGENESIS", Genetics, 148(4), 1998, pp. 1655-1665
99. MOILANEN E; THOMSEN LL; MILES DW; HAPPERFIELD L; KNOWLES RG; MONCADA S
    PERSISTENT INDUCTION OF NITRIC-OXIDE SYNTHASE IN TUMORS FROM MICE TREATED WITH THE ANTITUMOR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID
    British Journal of Cancer
    
    E. Moilanen et al., "PERSISTENT INDUCTION OF NITRIC-OXIDE SYNTHASE IN TUMORS FROM MICE TREATED WITH THE ANTITUMOR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID", British Journal of Cancer, 77(3), 1998, pp. 426-433
100. SCHEIBEL T; BUCHNER J
     THE HSP90 COMPLEX - A SUPER-CHAPERONE MACHINE AS A NOVEL DRUG TARGET
     Biochemical pharmacology
     
     T. Scheibel e J. Buchner, "THE HSP90 COMPLEX - A SUPER-CHAPERONE MACHINE AS A NOVEL DRUG TARGET", Biochemical pharmacology, 56(6), 1998, pp. 675-682